Aug 13th, 2010
The Center for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization Practices (ACIP) is updating its recommendations for the 2010-11 influenza season in the United States in light of data suggesting: increased risk of febrile seizures in children aged 6 months through 4 years following 2010 Fluvax or Fluvax Jr.; higher frequency of reported fever in ...
Jul 16th, 2010
Physicians will soon have a new test they can use to diagnose patients with the 2009 H1N1 influenza virus. Developed by the U.S. Centers for Disease Control and Prevention (CDC) and authorized for use June 22 by the U.S. Food and Drug Administration (FDA), the new test will replace the previous real-time RT-PCR diagnostic test ...
In Audit
Jul 2nd, 2010
New Category I CPT® influenza vaccine codes announced in 2009 and slated for publishing in the 2011 CPT® manual are effective July 1. All four codes have the pending approval icon as the vaccines are not yet approved by the U.S. Food and Drug Administration (FDA). 90664 Influenza virus vaccine, pandemic formulation, live, for intranasal use ...
Nov 16th, 2009
The U.S. Food and Drug Administration (FDA) has approved the use of CSL Limited’s 2009 H1N1 influenza vaccine to include children ages 6 months and older. The vaccine was previously approved only for use in adults, ages 18 years and older. The expanded approval also covers the Australian company’s seasonal flu vaccine. The vaccines will ...
In CMS
Nov 2nd, 2009
The Centers for Medicare & Medicaid Services (CMS) updated, Oct. 14, its Medicare Fee-for-Service (FFS) Q&As to address H1N1-related questions circling among the health care industry. Medicare FFS Q&A Addresses H1N1 was last modified: July 5th, 2011 by admin aapc...